Integrated bioinformatics and functional studies identify CDK9 as a potential prognostic biomarker and therapeutic target in AML
Abstract Background Acute myeloid leukemia (AML) is a highly heterogeneous disease characterized by complex genetic and molecular features that contribute to poor prognosis and low cure rates. Therefore, identifying novel therapeutic targets is crucial for improving treatment efficacy and patient su...
Saved in:
| Main Authors: | Zhibin Xie, Yang Xia, Zhongyu Li, Mengmeng Zhang, Yuanyuan Tan, Yuqing Han, Meng Wang, Pingping Zhang, Jiajia Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02841-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of new inhibitors of the kinase activity of CDK2 and CDK9 by molecular modeling and high-efficiency screening
by: G.V. Andrianov, et al.
Published: (2021-12-01) -
Identification and validation of pyroptosis patterns in AML via comprehensive bioinformatics analysis
by: Zeyu Deng, et al.
Published: (2025-04-01) -
Targeting CDK9 for treatment of colorectal cancer
by: Muhammed H. Rahaman, et al.
Published: (2019-10-01) -
Unraveling the CDK9/PP2A/ERK Network in Transcriptional Pause Release and Complement Activation in KRAS‐mutant Cancers
by: Yafang Wang, et al.
Published: (2024-11-01) -
METTL7A is a potential biomarker for the diagnosis and prognosis of acute myeloid leukemia
by: ZhiBin Xie, et al.
Published: (2025-12-01)